Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Evaluation of the Pharmacokinetics of Sublingual IPX237 in Healthy Volunteers


To see complete record on anzctr.org.au, please visit this link

Id: ACTRN12614000444684

Organisation Name: Impax Pharmaceuticals,A Division of Impax Laboratories, Inc.

Overal Status: Completed

Start Date: 01/07/2014

Brief Summary: To characterize the pharmacokinetics (PK), safety, and tolerability of sublingually administered esketamine hydrochloride from IPX237 at two dose strengths, and to evaluate the effect of formulation retention in the sublingual space.

Countries:
  • Australia
  • United States of America


Total execution time in seconds: 0.1679859161377